# Arix Bioscience: Multiple inflection points in 2020 (Interview)

- Link: https://www.directorstalkinterviews.com/arix-bioscience-should-have-a-really-strong-year-say-hardman-interview/412806877
- Published: 2020-02-28T07:44:38+00:00
- Author: Giles Arbor

**Arix Bioscience plc** (LON:ARIX) is the topic of conversation when Dr Dorothea
Hill, Analyst at Hardman & Co joins DirectorsTalk. Having recently initiated on 
Arix Bioscience Dorothea explains the key takeaways retail investors should be aware
of, how a generalist investor should assess the technology, how to assess Arix’s
Net Asset Value, expectations for full year results and what to look for going forward.

Arix Bioscience is a global venture capital company focused on investing in and 
building breakthrough biotech companies around cutting edge advances in life sciences.

They collaborate with exceptional entrepreneurs and provide the capital, expertise
and global networks to help accelerate their ideas into important new treatments
for patients. As a listed company, they are able to bring this exciting growth phase
of their industry to a broader range of investors.

Share on: